从心力衰竭的夜间氧度测试中预测的低血压负担的预后值,并保留了喷射分数
Sanne G J Mourmans1, Jerremy Weerts1, Mathias Baumert2
1Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.
ESC heart failure
|October 27, 2024
概括
夜间低氧症,以低于90%氧和时间 (T90) 测量,预测心力衰竭的不良结果与保存的射出分数 (HFpEF). 较高的T90水平与高心力衰竭患者的住院和死亡率增加有关.
科学领域:
- 心脏病学 心脏病学
- 睡眠医学 睡眠医学
- 肺部医学 肺部医学
背景情况:
- 夜间低氧症,以低于90%的氧和度 (T90) 度过的时间量化,是已知的心力衰竭的死亡预测因子.
- 在心力衰竭中T90的预后意义与保存的喷射分数 (HFpEF) 仍然在很大程度上未被探索.
- 了解T90在HFpEF中的作用对于识别风险患者和指导治疗策略至关重要.
研究的目的:
- 研究夜间低血压负担 (T90) 与HFpEF患者的不良临床结果之间的关联.
- 确定T90是否是心力衰竭住院或全因死亡的独立预测因素.
- 确定T90监测在HFpEF管理中的临床实用性.
主要方法:
- 预计将从一个专门的HFpEF门诊所招收126名患者.
- 门诊家庭睡眠监测,以收集氧度数据,特别是T90.
- 随访时间中位数为34个月,以评估HF住院或全因死亡的复合终点.
主要成果:
- 在HFpEF队列中,夜间低氧症很普遍,T90的中位数为13.7分钟.
- 在较高的T90和复合终点 (高频率住院或全因死亡率) 之间发现了显著的关联,即使经过对混因素进行调整.
- 在最高T90三位数 (≥31.4分钟) 的患者,与较低三位数 (15%) 的患者相比,事件发生率 (45%) 显著更高.
结论:
- 夜间低血压负担 (T90) 作为HFpEF中不良结果的独立预后标志物.
- 升高的T90水平与心力衰竭住院和全因死亡率的风险增加有关.
- 需要进一步的研究来探索T90减少对HFpEF预后的影响.
相关概念视频
Heart Failure VI: Adjunct Therapies
1
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
Respiratory Assessment: Purpose and Indications
1.0K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.0K
Acute Respiratory Failure-II
174
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174
Pulse Oximetry
311
Pulse oximetry, or SpO2, is a non-invasive method for continuously monitoring arterial oxygen saturation (SaO2). This procedure involves attaching a probe or sensor to the patient's fingertip, forehead, earlobe, or nose bridge. The sensor works by detecting changes in oxygen saturation levels through light signals generated by the oximeter and reflected by the pulsing blood under the probe.
Purpose
Average SpO2 values are greater than 95%. If the readings fall below 90%, it indicates that...
Purpose
Average SpO2 values are greater than 95%. If the readings fall below 90%, it indicates that...
311
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
177
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
177
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K


